Chronic obstructive pulmonary disease (COPD) and cardiovascular disease (CVD)
frequently occur together and their coexistence is associated with worse outcomes than …

Importance There are 30 million adults (12%) in the United States who have chronic
obstructive pulmonary disease (COPD). Chronic obstructive pulmonary disease accounts for …

Background Evidence is scarce on the relative risk-benefit of inhaled triple therapy,
consisting of inhaled corticosteroid, long-acting muscarinic antagonist, and long-acting β 2 …

Bronchodilators remain the cornerstone of the treatment of airway disorders such as asthma
and chronic obstructive pulmonary disease (COPD). There is therefore considerable interest …

Heart failure (HF) and chronic obstructive pulmonary disease (COPD) coincide in a
significant number of patients. Recent population-based registries suggest that spirometry is …

Over the last few years, there has been a renewed interest in patients with characteristics of
both asthma and COPD. Although the precise definition of asthma-COPD overlap (ACO) is …

Importance Chronic obstructive pulmonary disease (COPD) is a leading cause of morbidity
and mortality in the US. Objective To conduct a targeted systematic review to update the …

Highlights•Dual bronchodilator therapy has clinical benefits in COPD.•Combining a LABA
with a LAMA synergistically relaxes medium and small airways.•In some approved …

Chronic obstructive airway diseases such as chronic obstructive pulmonary disease
(COPD), asthma, rhinitis, and obstructive sleep apnea (OSA) are amongst the most common …

Background and objective Acute exacerbations in chronic obstructive pulmonary disease
(COPD) may trigger major adverse cardiac events (MACE). We aimed to determine whether …